Dr. Geraldine Walsh
Research 180 Video Competition: Share your research story
Thursday, August 25, 2022
Canadian Blood Services, in partnership with the Centre for Blood Research, just launched our first ever Research 180 Video Competition for trainees. Read on to learn more!
Research supports safety, feasibility of sexual behaviour-based screening
Tuesday, June 21, 2022
In late April 2022, Canadian Blood Services’ research-informed request to remove eligibility criteria specific to men who have sex with men and instead use sexual behaviour-based screening for all donors was approved by Health Canada. Read on to learn about two published studies from Canadian Blood Services that contributed to the body of evidence supporting this change.
Science writing behind the scenes
Thursday, June 09, 2022
We teamed up with Science Borealis and the Centre for Blood Research to deliver the 2021-2022 Canadian Blood Services Lay Science Writing Competition. In a recently published blog post, Science Borealis interviewed the winner of that competition, Alexandra Witt, to learn about her creative process and how she crafted a winning piece of writing.
Nominations open for the Lifetime Achievement Award 2022
Monday, April 25, 2022
Consider submitting a nomination for this prestigious award that recognizes individuals whose landmark contributions are recognized as both extraordinary and world class in the field of transfusion or transplantation medicine, stem cell or cord blood research in Canada and/or abroad. You have until May 16, 2022 to get your nominations in!
Product resiliency: future-proofing our product portfolio
Thursday, March 31, 2022
Dr. Cyrus Eduljee, associate director of portfolio management at Canadian Blood Services, explains how his group’s work supports the organization in bringing new products to the shelves and the importance of ensuring the organization is well prepared to withstand future shocks.
Introducing pathogen-reduced platelets
Thursday, March 24, 2022
In January 2022, Canadian Blood Services introduced pathogen-reduced platelets, a product that is manufactured using pathogen-inactivation technology, at its Ottawa production site. By effectively damaging the nucleic acids of a number of pathogens, pathogen inactivation further reduces the risk of transfusion-transmitted infections—an especially important safeguard against new or emerging pathogens, or pathogens for which tests are not available.
Science behind the scenes: Lay Science Writing Competition winners announced
Friday, March 18, 2022
The Canadian Blood Services Lay Science Writing Competition supports our trainee network to develop communication skills by challenging them to showcase their research using plain language.
Student advocates, plasma donation and the pandemic
Thursday, February 24, 2022
A study conducted last year by Canadian Blood Services’ social scientist, Dr. Kelly Holloway, shows challenges and opportunities for on-campus student advocates as they engage with their peers to encourage blood and plasma donation, all while navigating the COVID-19 pandemic.
Whole blood for transfusion: development work supports operational feasibility
Thursday, February 10, 2022
Development work by Canadian Blood Services’ product and process development group lays the groundwork for greater operational flexibility for blood operators looking to introduce whole blood for transfusion.
Research evidence helps support submission to change donor screening
Thursday, January 13, 2022
Canadian Blood Services recently made a submission to Health Canada to focus donor screening criteria on higher-risk sexual behaviour, regardless of gender or sexuality, for all donors and all phlebotomy collection types.